Nucleolar Organizing Regions and α-Smooth Muscle Actin Expression in a Case of Ameloblastic Carcinoma

• Published in: Head & neck pathology (Totowa, N.J.) Vol. 4; no. 2; pp. 157 - 162
• Main Authors: Kamath, Kavitha P., Vidya, M., Shetty, Nandaprasad, Karkera, Bhavana V., Jogi, Hemanth
• Format: Journal Article
• Language: English
• Published: New York Humana Press Inc 01.06.2010
• Subjects: Actins - metabolism; Ameloblastoma - genetics; Ameloblastoma - metabolism; Ameloblastoma - pathology; Antigens, Nuclear - analysis; Antigens, Nuclear - genetics; Biomarkers, Tumor - metabolism; Carcinoma - genetics; Carcinoma - metabolism; Carcinoma - pathology; Case Report; Dentistry; Diagnosis, Differential; Humans; Immunohistochemistry; Male; Mandible - pathology; Mandible - surgery; Mandibular Neoplasms - genetics; Mandibular Neoplasms - metabolism; Mandibular Neoplasms - pathology; Medicine; Medicine & Public Health; Middle Aged; Nucleolus Organizer Region - metabolism; Nucleolus Organizer Region - pathology; Oral and Maxillofacial Surgery; Otorhinolaryngology; Pathology; Ameloblastoma; Smooth muscle actin; AgNORs; Odontogenic; Ameloblastic carcinoma; Epithelial
• ISSN: 1936-055X; 1936-0568
• DOI: 10.1007/s12105-010-0173-7

Ameloblastic carcinoma is a rare lesion of odontogenic origin. It is defined as a malignant epithelial odontogenic tumor that histologically has retained the features of ameloblastic differentiation and also exhibits cytologic features of malignancy, like atypia and mitotic activity. Although this lesion represents a separate entity, differentiating it from ameloblastoma has been often challenging to pathologists. In this case study reporting a case of ameloblastic carcinoma, we have attempted to verify the previous findings on the use of Argyrophilic nucleolar organizing regions (AgNORs) and immunohistochemical staining for the alpha-smooth muscle actin (alpha-SMA) in differentiating ameloblastic carcinoma from ameloblastoma. It was observed that AgNORs was found to be almost twice in ameloblastic carcinoma as it was in ameloblastoma. A difference between the two lesions in the pattern of expression of alpha-SMA was also observed, with alpha-SMA being expressed in the odontogenic epithelium and the stroma of ameloblastic carcinoma whereas, in the case of ameloblastoma, it was found only in the stromal part. These findings suggest that AgNORs and alpha-SMA expression may be used as adjuncts to the routine histopathologic examination to differentiate ameloblastic carcinoma and ameloblastoma.